$ELV
Elevance Health, Inc. Stock $elv

$elv Overview Financials Valuation SEC Filings Company Website

2012 Q1 Form 10-Q Financial Statement

#000119312512182273 Filed on April 25, 2012

Income Statement

Concept	2012 Q1	2011 Q1
Revenue	$15.42B	$14.89B
YoY Change	3.5%	-1.32%
Cost Of Revenue	$0.00	$11.23B
YoY Change	-100.0%
Gross Profit	$15.42B	$3.666B
YoY Change	320.46%
Gross Profit Margin	100.0%	24.62%
Selling, General & Admin	$2.166B	$2.077B
YoY Change	4.3%	-4.48%
% of Gross Profit	14.05%	56.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$23.50M	$23.40M
YoY Change	0.43%	-83.29%
% of Gross Profit	0.15%	0.64%
Operating Expenses	$2.166B	$2.077B
YoY Change	4.3%	-84.75%
Operating Profit	$1.213B	$1.350B
YoY Change	-10.2%
Interest Expense	$109.1M	$105.9M
YoY Change	3.02%	-206.97%
% of Operating Profit	9.0%	7.84%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.310B	$1.427B
YoY Change	-8.22%	6.9%
Income Tax	$453.3M	$500.5M
% Of Pretax Income	34.61%	35.07%
Net Earnings	$856.5M	$926.6M
YoY Change	-7.57%	5.66%
Net Earnings / Revenue	5.56%	6.22%
Basic Earnings Per Share	$2.56	$2.48
Diluted Earnings Per Share	$2.53	$2.44
COMMON SHARES
Basic Shares Outstanding	335.0M shares	374.0M shares
Diluted Shares Outstanding	339.0M shares	379.3M shares

Balance Sheet

Concept	2012 Q1	2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.48B
YoY Change
Cash & Equivalents	$2.279B	$2.402B
Short-Term Investments	$16.20B
Other Short-Term Assets	$1.921B
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$27.54B	$917.0M
YoY Change	2903.66%	-11.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.455B	$1.186B
YoY Change	22.65%	3.58%
Goodwill	$13.86B
YoY Change
Intangibles	$7.878B
YoY Change
Long-Term Investments	$18.76B	$18.31B
YoY Change	2.46%	3.19%
Other Assets	$445.7M	$1.246B
YoY Change	-64.23%	15.16%
Total Long-Term Assets	$24.95B	$50.00B
YoY Change	-50.1%	-0.28%
TOTAL ASSETS
Total Short-Term Assets	$27.54B	$917.0M
Total Long-Term Assets	$24.95B	$50.00B
Total Assets	$52.50B	$50.92B
YoY Change	3.1%	-0.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.810B	$2.667B
YoY Change	5.36%	-0.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$100.0M	$100.0M
YoY Change	0.0%
Long-Term Debt Due	$910.8M	$359.0M
YoY Change	153.7%	-52.76%
Total Short-Term Liabilities	$15.96B	$4.430B
YoY Change	260.16%	-5.6%
LONG-TERM LIABILITIES
Long-Term Debt	$8.463B	$8.542B
YoY Change	-0.93%	11.95%
Other Long-Term Liabilities	$1.025B	$3.150B
YoY Change	-67.46%	-10.51%
Total Long-Term Liabilities	$9.488B	$11.69B
YoY Change	-18.85%	4.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.96B	$4.430B
Total Long-Term Liabilities	$9.488B	$11.69B
Total Liabilities	$28.97B	$26.94B
YoY Change	7.53%	1.04%
SHAREHOLDERS EQUITY
Retained Earnings	$11.92B
YoY Change
Common Stock	$3.300M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$23.53B	$23.98B
YoY Change
Total Liabilities & Shareholders Equity	$52.50B	$50.92B
YoY Change	3.1%	-0.51%

Cashflow Statement

Concept	2012 Q1	2011 Q1
OPERATING ACTIVITIES
Net Income	$856.5M	$926.6M
YoY Change	-7.57%	5.66%
Depreciation, Depletion And Amortization	$23.50M	$23.40M
YoY Change	0.43%	-83.29%
Cash From Operating Activities	$1.223B	$1.115B
YoY Change	9.7%	-445.17%
INVESTING ACTIVITIES
Capital Expenditures	$123.8M	$101.9M
YoY Change	21.49%	-184.92%
Acquisitions	$1.200M	$0.00
YoY Change
Other Investing Activities	$600.0K	$13.40M
YoY Change	-95.52%	-95.71%
Cash From Investing Activities	$20.10M	$282.1M
YoY Change	-92.87%	46.93%
FINANCING ACTIVITIES
Cash Dividend Paid	$95.80M	$92.80M
YoY Change	3.23%
Common Stock Issuance & Retirement, Net	$679.8M	$741.6M
YoY Change	-8.33%	-156.22%
Debt Paid & Issued, Net	$350.8M	$700.8M
YoY Change	-49.94%
Cash From Financing Activities	-$1.167B	-$785.8M
YoY Change	48.51%	-32.14%
NET CHANGE
Cash From Operating Activities	$1.223B	$1.115B
Cash From Investing Activities	$20.10M	$282.1M
Cash From Financing Activities	-$1.167B	-$785.8M
Net Change In Cash	$76.20M	$611.2M
YoY Change	-87.53%	-147.42%
FREE CASH FLOW
Cash From Operating Activities	$1.223B	$1.115B
Capital Expenditures	$123.8M	$101.9M
Free Cash Flow	$1.099B	$1.013B
YoY Change	8.52%	-599.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q1	dei	Document Period End Date DocumentPeriodEndDate	2012-03-31
CY2012Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012Q1	dei	Document Type DocumentType	10-Q
CY2012Q1	dei	Amendment Flag AmendmentFlag	false
CY2012Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2012Q1	dei	Trading Symbol TradingSymbol	WLP
CY2012Q1	dei	Entity Registrant Name EntityRegistrantName	WellPoint, Inc.
CY2012Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001156039
CY2012Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2012Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	330829747	shares
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2279100000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	16196500000	USD
CY2012Q1	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1224400000	USD
CY2012Q1	us-gaap	Other Short Term Investments OtherShortTermInvestments	21600000	USD
CY2012Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	167300000	USD
CY2012Q1	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	3722100000	USD
CY2012Q1	us-gaap	Other Receivables OtherReceivables	943200000	USD
CY2012Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2012Q1	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	715500000	USD
CY2012Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	353300000	USD
CY2012Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1920600000	USD
CY2012Q1	us-gaap	Assets Current AssetsCurrent	27543600000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	245300000	USD
CY2012Q1	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	29300000	USD
CY2012Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments	1041300000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1454600000	USD
CY2012Q1	us-gaap	Goodwill Goodwill	13858600000	USD
CY2012Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7878100000	USD
CY2012Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	445700000	USD
CY2012Q1	us-gaap	Assets Assets	52496500000	USD
CY2012Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	5403300000	USD
CY2012Q1	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	60800000	USD
CY2012Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2257600000	USD
CY2012Q1	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	7721700000	USD
CY2012Q1	us-gaap	Unearned Premiums UnearnedPremiums	1624100000	USD
CY2012Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2809900000	USD
CY2012Q1	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	146800000	USD
CY2012Q1	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	715900000	USD
CY2012Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	100000000	USD
CY2012Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	910800000	USD
CY2012Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1660100000	USD
CY2012Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15955100000	USD
CY2012Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8462500000	USD
CY2012Q1	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	752300000	USD
CY2012Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2773200000	USD
CY2012Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1025000000	USD
CY2012Q1	us-gaap	Liabilities Liabilities	28968100000	USD
CY2012Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2012Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	3300000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	424800000	USD
CY2011Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1859000000	USD
CY2012Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11369000000	USD
CY2012Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11921100000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	235000000	USD
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	23528400000	USD
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52496500000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2201600000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	15913100000	USD
CY2011Q4	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1188100000	USD
CY2011Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	14800000	USD
CY2011Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	172000000	USD
CY2011Q4	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	3402900000	USD
CY2011Q4	us-gaap	Other Receivables OtherReceivables	943900000	USD
CY2011Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	105800000	USD
CY2011Q4	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	871400000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	27097400000	USD
CY2011Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	246800000	USD
CY2011Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	28800000	USD
CY2011Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	1003700000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1418100000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	13858700000	USD
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7931700000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	433600000	USD
CY2011Q4	us-gaap	Assets Assets	52018800000	USD
CY2011Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	5489000000	USD
CY2011Q4	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	55100000	USD
CY2011Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2278200000	USD
CY2011Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	7822300000	USD
CY2011Q4	us-gaap	Unearned Premiums UnearnedPremiums	926500000	USD
CY2011Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3124100000	USD
CY2011Q4	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	51700000	USD
CY2011Q4	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	872500000	USD
CY2011Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	100000000	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1274500000	USD
CY2011Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1654100000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15825700000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8420900000	USD
CY2011Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	730700000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2724000000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1029300000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	28730600000	USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	3400000	USD
CY2011Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11679200000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11490700000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	114900000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	23288200000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52018800000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	15449100000	USD
CY2012Q1	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	871000000	USD
CY2012Q1	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	240200000	USD
CY2012Q1	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	26800000	USD
CY2012Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2012Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2012Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2012Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	331807383	shares
CY2012Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	331807383	shares
CY2011Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	15233600000	USD
CY2011Q4	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	937700000	USD
CY2011Q4	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	240800000	USD
CY2011Q4	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	28400000	USD
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	339372680	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	339372680	shares
CY2012Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	265800000	USD
CY2011Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2012Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	14138500000	USD
CY2012Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	995800000	USD
CY2012Q1	us-gaap	Other Income OtherIncome	15900000	USD
CY2012Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	15150200000	USD
CY2012Q1	us-gaap	Net Investment Income NetInvestmentIncome	169000000	USD
CY2012Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	106900000	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	13700000	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-2800000	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	10900000	USD
CY2012Q1	us-gaap	Revenues Revenues	15415200000	USD
CY2011Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	13684100000	USD
CY2011Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	962000000	USD
CY2011Q1	us-gaap	Other Income OtherIncome	8700000	USD
CY2011Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	14654800000	USD
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.56
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.53
CY2011Q1	us-gaap	Net Investment Income NetInvestmentIncome	184800000	USD
CY2011Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	57100000	USD
CY2012Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.2875
CY2011Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	4800000	USD
CY2011Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-2400000	USD
CY2011Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	2400000	USD
CY2011Q1	us-gaap	Revenues Revenues	14894300000	USD
CY2012Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	11771900000	USD
CY2012Q1	us-gaap	Selling Expense SellingExpense	393300000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1772400000	USD
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2165700000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	109100000	USD
CY2012Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	58700000	USD
CY2012Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	14105400000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1309800000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	453300000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	856500000	USD
CY2011Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	11228000000	USD
CY2011Q1	us-gaap	Selling Expense SellingExpense	397000000	USD
CY2011Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1679500000	USD
CY2011Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2076500000	USD
CY2011Q1	us-gaap	Interest Expense InterestExpense	105900000	USD
CY2011Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56800000	USD
CY2011Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	13467200000	USD
CY2011Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1427100000	USD
CY2011Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500500000	USD
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	926600000	USD
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.48
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.44
CY2011Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.25
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	107300000	USD
CY2012Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-4800000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	600000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	6700000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	700000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	12800000	USD
CY2011Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-4300000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	400000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease	8300000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	1000000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	976600000	USD
CY2011Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	953400000	USD
CY2012Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	21300000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1223100000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	32500000	USD
CY2012Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	155200000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	74300000	USD
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	19300000	USD
CY2012Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-300000	USD
CY2012Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	302300000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-388300000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	391000000	USD
CY2012Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-79000000	USD
CY2012Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	59900000	USD
CY2012Q1	us-gaap	Depreciation Depreciation	23500000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	10000000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2900000	USD
CY2012Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	697600000	USD
CY2012Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3252400000	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2731500000	USD
CY2012Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	477600000	USD
CY2012Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	100400000	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	163700000	USD
CY2012Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	34700000	USD
CY2012Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	3800000	USD
CY2012Q1	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	-156600000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	123800000	USD
CY2012Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	600000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	20100000	USD
CY2012Q1	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	37800000	USD
CY2012Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	350800000	USD
CY2012Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	100000000	USD
CY2012Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	100000000	USD
CY2012Q1	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	-156600000	USD
CY2012Q1	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	23200000	USD
CY2012Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	679800000	USD
CY2012Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	95800000	USD
CY2012Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	35700000	USD
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	19300000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1167000000	USD
CY2012Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1300000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	77500000	USD
CY2011Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	47500000	USD
CY2011Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	11000000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	282100000	USD
CY2011Q1	us-gaap	Depreciation Depreciation	23400000	USD
CY2011Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	22600000	USD
CY2011Q1	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	-111700000	USD
CY2011Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	2965000000	USD
CY2011Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	268200000	USD
CY2011Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	160300000	USD
CY2011Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	741600000	USD
CY2011Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	443800000	USD
CY2012Q1	wlp	Number Of Counties In State Of Kansas Company Does Not Serve NumberOfCountiesInStateOfKansasCompanyDoesNotServe	30	pure
CY2011Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	100000000	USD
CY2011Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	22600000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	613200000	USD
CY2011Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	44700000	USD
CY2011Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2545500000	USD
CY2011Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	700800000	USD
CY2011Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	11900000	USD
CY2011Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	100000000	USD
CY2011Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	127300000	USD
CY2011Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-344100000	USD
CY2011Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2000000	USD
CY2011Q1	us-gaap	Share Based Compensation ShareBasedCompensation	22600000	USD
CY2011Q1	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	27900000	USD
CY2011Q1	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	-111600000	USD
CY2011Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	101900000	USD
CY2011Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	34200000	USD
CY2011Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	309400000	USD
CY2011Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	790800000	USD
CY2011Q1	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	763100000	USD
CY2011Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	7600000	USD
CY2011Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-67300000	USD
CY2011Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	133800000	USD
CY2011Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	92800000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-785800000	USD
CY2011Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-600000	USD
CY2011Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	13400000	USD
CY2011Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	74900000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1114900000	USD
CY2011Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	156600000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2402000000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1788800000	USD
CY2012Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1200000	USD
CY2011Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2012Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	679800000	USD
CY2012Q1	us-gaap	Dividends Common Stock DividendsCommonStock	96700000	USD
CY2012Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	40100000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	23812600000	USD
CY2011Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	741600000	USD
CY2011Q1	us-gaap	Dividends Common Stock DividendsCommonStock	93800000	USD
CY2011Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	47500000	USD
CY2011Q1	us-gaap	Stockholders Equity StockholdersEquity	23978100000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	120100000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	26800000	USD
CY2012Q1	wlp	Number Of Commercial Medical Members NumberOfCommercialMedicalMembers	33700000	pure
CY2012Q1	wlp	Number Of Individuals Members NumberOfIndividualsMembers	62300000	pure
CY2012Q1	wlp	Number Of Counties In New York City Metropolitan Area Company Serves As Independent Licensee NumberOfCountiesInNewYorkCityMetropolitanAreaCompanyServesAsIndependentLicensee	10	pure
CY2012Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;margin-left:0px;">1</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;">. Organization</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">References to the terms “we”, “our”, “us”, “WellPoint” or the “Company” used throughout these Notes to Consolidated Financial Statements refer to WellPoint, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">We are </font><font style="font-family:Times New Roman;font-size:10pt;">one of the </font><font style="font-family:Times New Roman;font-size:10pt;">largest</font><font style="font-family:Times New Roman;font-size:10pt;"> health benefits companies</font><font style="font-family:Times New Roman;font-size:10pt;"> in terms of </font><font style="font-family:Times New Roman;font-size:10pt;">medical</font><font style="font-family:Times New Roman;font-size:10pt;"> membership in the United</font><font style="font-family:Times New Roman;font-size:10pt;"> States, serving </font><font style="font-family:Times New Roman;font-size:10pt;">33.7</font><font style="font-family:Times New Roman;font-size:10pt;"> medical members through our affiliated health plans and a total of more than </font><font style="font-family:Times New Roman;font-size:10pt;">62.3</font><font style="font-family:Times New Roman;font-size:10pt;"> individuals through our subsidiaries as of </font><font style="font-family:Times New Roman;font-size:10pt;">March 31</font><font style="font-family:Times New Roman;font-size:10pt;">, </font><font style="font-family:Times New Roman;font-size:10pt;">2012</font><font style="font-family:Times New Roman;font-size:10pt;">. We offer a broad spectrum of network-based managed care plans to large and small employer, individual, Medicaid and senior markets. Our managed care plans include: preferred provider organizations, or PPOs; health maintenance organizations, or HMOs; point-of-service, or POS, plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans, or CDHPs; and hospital only and limited benefit products. In addition, we provide a broad array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. We also provide an array of specialty and other products and services such as life and disability insurance benefits, dental, vision, behavioral health benefit services, radiology benefit management, analytics-driven personal health care guidance and long-term care insurance. </font><font style="font-family:Times New Roman;font-size:10pt;">Finally, we provide services to the Federal Government in connection with the Federal Employee Program, or FEP, and various Medicare programs.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:18px;">We are an independent licensee of the Blue Cross and Blue Shield Association, or BCBSA, an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California; the Blue Cross and Blue Shield, or BCBS, licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding </font><font style="font-family:Times New Roman;font-size:10pt;">30</font><font style="font-family:Times New Roman;font-size:10pt;"> counties in the Kansas City area), Nevada, New Hampshire, New York (as the BCBS licensee in </font><font style="font-family:Times New Roman;font-size:10pt;">10</font><font style="font-family:Times New Roman;font-size:10pt;"> New York City metropolitan and surrounding counties and as the Blue Cross or BCBS licensee in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross Blue Shield, or Empire Blue Cross (in our </font><font style="font-family:Times New Roman;font-size:10pt;">New York</font><font style="font-family:Times New Roman;font-size:10pt;"> service areas). We also serve customers throughout the country as UniCare</font><font style="font-family:Times New Roman;font-size:10pt;">, and in certain California, Arizona and Nevada markets through our CareMore Health Group, Inc., or CareMore, subsidiary</font><font style="font-family:Times New Roman;font-size:10pt;">.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">We are licensed to conduct insurance operations in all </font><font style="font-family:Times New Roman;font-size:10pt;">50</font><font style="font-family:Times New Roman;font-size:10pt;"> states through our subsidiaries.</font></p>
CY2012Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	50	pure
CY2012Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1190300000	USD
CY2012Q1	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses1	-50600000	USD
CY2012Q1	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses1	-31300000	USD
CY2012Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	17695500000	USD
CY2011Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	16440500000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	1107100000	USD
CY2011Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses1	-129200000	USD
CY2011Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses1 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses1	-41600000	USD
CY2011Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	17376800000	USD
CY2012Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	16587100000	USD
CY2012Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	17695500000	USD
CY2012Q1	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	1787000000	USD
CY2012Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2235100000	USD
CY2011Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	2352000000	USD
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	2480000000	USD
CY2012Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	282200000	USD
CY2011Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	221000000	USD
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	356900000	USD
CY2012Q1	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	233000000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	732100000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	4617500000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	3226000000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	2665800000	USD
CY2012Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2012-01-24
CY2012Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1267600000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	754100000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	4821300000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	4712800000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	3375100000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	2778500000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	4447900000	USD
CY2012Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	156200000	USD
CY2012Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	49300000	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2894500000	USD
CY2012Q1	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	19776200000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	1675800000	USD
CY2011Q4	us-gaap	Assets Fair Value Disclosure Recurring AssetsFairValueDisclosureRecurring	20025400000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	14900000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	-20200000	USD
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	284800000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	18800000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-1900000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-52200000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	1400000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	105700000	USD
CY2012Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-400000	USD
CY2010Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	388700000	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	-600000	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	3800000	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0	USD
CY2011Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss Included In Investment Income FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLossIncludedInInvestmentIncome	-1600000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	139900000	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	363600000	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	16300000	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-27100000	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	0	USD
CY2011Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-17500000	USD
CY2012Q1	us-gaap	Fair Value Level1 To Level2 Transfers Amount FairValueLevel1ToLevel2TransfersAmount	0	USD
CY2011Q1	us-gaap	Fair Value Level1 To Level2 Transfers Amount FairValueLevel1ToLevel2TransfersAmount	0	USD
CY2012Q1	us-gaap	Fair Value Level2 To Level1 Transfers Amount FairValueLevel2ToLevel1TransfersAmount	0	USD
CY2011Q1	us-gaap	Fair Value Level2 To Level1 Transfers Amount FairValueLevel2ToLevel1TransfersAmount	0	USD
CY2012Q1	wlp	Number Of Assets Measured At Fair Value On Nonrecurring Basis NumberOfAssetsMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2011Q1	wlp	Number Of Assets Measured At Fair Value On Nonrecurring Basis NumberOfAssetsMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2012Q1	wlp	Number Of Liabilities Measured At Fair Value On Nonrecurring Basis NumberOfLiabilitiesMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2011Q1	wlp	Number Of Liabilities Measured At Fair Value On Nonrecurring Basis NumberOfLiabilitiesMeasuredAtFairValueOnNonrecurringBasis	0	USD
CY2012Q1	us-gaap	Commercial Paper CommercialPaper	837600000	USD
CY2012Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	9530800000	USD
CY2012Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	USD
CY2012Q1	wlp	Expected Material Contribution ExpectedMaterialContribution	0	USD
CY2011Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	USD
CY2012Q1	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.0037	pure
CY2012Q1	us-gaap	Proceeds From Federal Home Loan Bank Advances ProceedsFromFederalHomeLoanBankAdvances	100000000	USD
CY2012Q1	us-gaap	Long Term Debt Percentage Bearing Fixed Interest Rate LongTermDebtPercentageBearingFixedInterestRate	0.0143	pure
CY2012Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2012-04-09
CY2012Q1	us-gaap	Line Of Credit Facility Expiration Date LineOfCreditFacilityExpirationDate	2016-09-29
CY2012Q1	us-gaap	Loss Contingency Range Of Possible Loss Minimum LossContingencyRangeOfPossibleLossMinimum	0	USD
CY2012Q1	us-gaap	Loss Contingency Range Of Possible Loss Maximum LossContingencyRangeOfPossibleLossMaximum	500000000	USD
CY2012Q2	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	71.91
CY2011Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2011-02-22
CY2011Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2011-03-10
CY2012Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2012-03-09
CY2012Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2012-03-23
CY2011Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2011-03-25
CY2012Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1100000	shares
CY2012Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	10200000	shares
CY2011Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	11400000	shares
CY2012Q1	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	66.80
CY2011Q1	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	65.29
CY2012Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	76000000	USD
CY2012Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	3577900000	USD
CY2012Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	3653900000	USD
CY2011Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	882000000	USD
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20000000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1700000	shares
CY2012Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-1300000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-200000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	20200000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	16800000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	62.30
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	66.23
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	47.08
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	66.40
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	63.58
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	63.28
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue	61.46
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	64.99
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4000000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	211100000	USD
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	56.00
CY2012Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	3.9	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	3.4	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	240800000	USD
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1700000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-2000000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-100000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3600000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	66.23
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	48.44
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.01410	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.34000	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00400	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm	4.1	pure
CY2011Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm	4.0	pure
CY2011Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.02840	pure
CY2011Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.34000	pure
CY2011Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.00379	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	16.51
CY2011Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.78
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	335000000	shares
CY2011Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	374000000	shares
CY2012Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4000000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	339000000	shares
CY2011Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	5300000	shares
CY2011Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	379300000	shares
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10100000	shares
CY2011Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12000000	shares
CY2012Q1	wlp	Potentially Dilutive Restricted Stock Units Contingent On Operating Results PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults	800000	shares
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1212600000	USD
CY2011Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1350300000	USD

Files In Submission

Name	View Source	Status
0001193125-12-182273-index-headers.html	Edgar Link	pending
0001193125-12-182273-index.html	Edgar Link	pending
0001193125-12-182273.txt	Edgar Link	pending
0001193125-12-182273-xbrl.zip	Edgar Link	pending
d321993d10q.htm	Edgar Link	pending
d321993dex102p.htm	Edgar Link	pending
d321993dex102q.htm	Edgar Link	pending
d321993dex311.htm	Edgar Link	pending
d321993dex312.htm	Edgar Link	pending
d321993dex321.htm	Edgar Link	pending
d321993dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wlp-20120331.xml	Edgar Link	completed
wlp-20120331.xsd	Edgar Link	pending
wlp-20120331_cal.xml	Edgar Link	unprocessable
wlp-20120331_def.xml	Edgar Link	unprocessable
wlp-20120331_lab.xml	Edgar Link	unprocessable
wlp-20120331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELV
Elevance Health, Inc. Stock $elv

2012 Q1 Form 10-Q Financial Statement

#000119312512182273 Filed on April 25, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV Elevance Health, Inc. Stock $elv

2012 Q1 Form 10-Q Financial Statement

#000119312512182273 Filed on April 25, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV
Elevance Health, Inc. Stock $elv